𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of dihydropyridine calcium antagonist binding sites in the rat hippocampus following neurochemical lesions

✍ Scribed by Dr. G. T. Bolger; A. S. Basile; A. J. Janowsky; S. M. Paul; P. Skolnick


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
618 KB
Volume
17
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


The effects of catecholaminergic, cholinergic, serotonergic, and glutaminergic terminal destruction and neurotransmitter depletion on r3H]nitrendipine binding to rat brain membranes were determined using the neurotoxins 6-hydroxydopamine, 5,7-dihydroxytryptamine, and kainic acid and the neurotransmitter-depleting agent reserpine. Following intracisternal injection of 6-hydroxydopamine there were time-dependent increases (14-23%) in the density but not change in the affinity of hippocampal [3H]nitrendipine binding sites. 6-Hydroxydopamine significantly increased ["nitrendipine binding in the hippocampus 4 and 10 days following injection. However, no significant change in binding was observed at 16 and 26 days. r3HJNitrendipine binding in the cerebral cortex, striatum, cerebellum, and brain stem was unaffected by 6-hydroxydopamine. Neither 5,7-dihydroxytryptamine nor kainic acid affected [3HJnitrendipine binding in the hippocampus and cerebral cortex. Acute and chronic reserpinization also did not affect r3H]nitrendipine binding in the hippocampus and cerebral cortex. These results indicate that dihydropyridine calcium antagonist bindings sites in rat brain are subject to brain region-specific regulation following neurochemical lesions and may be present in their largest densities on postsynaptic membranes.


📜 SIMILAR VOLUMES


Regulation of the number of α-bungarotox
✍ H. Smilowitz; E. Smart; C. Bowik; R.-J. Chang 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Calcium has been suggested as the second messenger link between skeletal muscle activity and AChR gene expression and synthesis. We have compared the concentrations of the Ca2+ channel antagonists D600 and nisoldipine needed both to block Ca2+ uptake into cultured myotubes and to increase AChR expre